Taiwan Advance Bio-Pharmaceutical (ROCO:4186) COGS-to-Revenue : 0.29 (As of Dec. 2023)

Taiwan Advance Bio-Pharmaceutical COGS-to-Revenue Chart

Taiwan Advance Bio-Pharmaceutical Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
COGS-to-Revenue		Get a 7-Day Free Trial					0.46	0.46	0.49	0.39	0.37

Taiwan Advance Bio-Pharmaceutical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.51	0.38	0.41	0.49	0.29

Taiwan Advance Bio-Pharmaceutical COGS-to-Revenue Calculation

Taiwan Advance Bio-Pharmaceutical's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Taiwan Advance Bio-Pharmaceutical's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiwan Advance Bio-Pharmaceutical  (ROCO:4186) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Taiwan Advance Bio-Pharmaceutical's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Taiwan Advance Bio-Pharmaceutical COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Taiwan Advance Bio-Pharmaceutical's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Business Description